Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

stocks1

Weekly Movers: Teva, Midatech, Allergan…

May 16, 2016 Research and Development, Sales and Marketing Allergan, Ariad Pharmaceuticals, Lundbeck, Midatech Pharma, Stock, Teva Pharmaceutical, markets

We have hit the tail end of the earnings season and the near last batch of movers follow result pronouncements …
Feature
174571_1

Novartis says trials show its COPD drug more effective versus GSK’s Seretide

May 16, 2016 Research and Development, Sales and Marketing GSK, Novartis, drug trial, research

Swiss drug firm Novartis (VTX: NOVN) said its asthma drug showed efficacy over GlaxoSmithKline’s (LSE: GSK) medicine in a comparison …
News
trials

Eisai granted additional indication for Lenvima in renal cell carcinoma

May 16, 2016 Sales and Marketing Eisai, additional indication, renal cell carcinoma

Eisai has announced that it has received approval from the US Food and Drug Administration (FDA) for an additional indication …
News
doc_writing

US pass new laws to combat opioid epidemic

May 13, 2016 Medical Communications, Sales and Marketing US, epidemic, fight back, new laws, opioids, reverse

The US has passed new laws that will seek to combat the current epidemic of opioids across the country. The …
News
sanofi_pasteur_scientist

Sanofi Files Hart-Scott-Rodino notification for Medivation acquisition

May 13, 2016 Medical Communications, Sales and Marketing M&A, MA, Medivation, Sanofi, deal

French drugmaker Sanofi (Euronext: SAN) on Friday said it has filed a premerger notification with the US Department of Justice Antitrust …
News
biogen_logo

Sobi, Biogen’s haemophilia B therapy gets European approval

May 13, 2016 Medical Communications, Research and Development, Sales and Marketing Biogen, haemophilia B, orphan designation, regulation, sobi

Sobi (STO: SOBI) and Biogen (Nasdaq: BIIB) on Friday said the European Commission has approved their drug to treat haemophilia B. The …
News
james_kehoe

Takeda appoints new chief financial officer

May 12, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe

Takeda Pharmaceuticals has named James Kehoe its new chief financial officer. He will begin the role on June 15 2016, …
Appointment

Almost 9 in 10 CCGs not implementing NICE guidelines on antibiotic resistance

May 12, 2016 Research and Development, Sales and Marketing CCGs, NICE, antibiotic resistance, failure

The Patients Association has called on all Clinical Commissioning Groups (CCGs) to implement the National Institute for Health and Care …
News

BMS says Nice refuses backing for its immunotherapy Opdivo to treat lung cancer

May 12, 2016 Medical Communications, Research and Development, Sales and Marketing

The National Institute for Health and Care Excellence (Nice) has rejected US pharma firm Bristol-Myers Squibb’s (NYSE: BMY) immune-oncology drug …
News

Multiple myeloma treatment from BMS and AbbVie scores EU approval

May 12, 2016 Research and Development, Sales and Marketing AbbVie, BMS, EMA, EU, Empliciti, approval, bristl-myers squibb, elotuzumab, multiple myeloma

Bristol-Myers Squibb (NYSE: BMY) and AbbVie (NYSE: ABBV) have announced that the European Commission has approved Empliciti (elotuzumab) for the …
News
lilly_entrance_web

FDA issues warning about rare, but serious, side effect in Lilly antipsychotic drug

May 12, 2016 Medical Communications, Sales and Marketing Eli Lilly, FDA, anti-psychotic, boxed warning, lilly, olanzapine, skin condition

The US Food and Drug Administration (FDA) has issued a new warning to all drug labels for Eli Lilly’s antipsychotic …
News
azhqlondonweb

AstraZeneca says its trial drug for thyroid cancer granted US FDA orphan drug designation

May 12, 2016 Research and Development, Sales and Marketing AstraZeneca, Orphan Drug Designation, US FDA, drug trial, regulation

AstraZeneca (LSE: AZN) on Thursday said the US Food and Drug Administration (FDA) has granted Orphan Drug Designation its trial …
News

Nice recommends two blood tests to rule out pre-eclampsia in pregnant women

May 11, 2016 Medical Communications, Sales and Marketing NICE, Roche, regulation

The National Institute for Health and Care Excellence (Nice) has backed two blood tests to help rule-out a complication in …
News
gsk_l_rgb

Nice backs GSK’s lupus drug Benlysta

May 11, 2016 Research and Development, Sales and Marketing GSK, NHS, NICE, regulation

The National Institute for Health and Care Excellence (Nice) has backed GlaxoSmithKline’s (LSE: GSK) Benlysta (belimumab) to treat lupus.  The …
News
sovaldi-web

Gilead’s Sovaldi gets Indian patent; critics call it “major blow” to patient access

May 11, 2016 Manufacturing and Production, Research and Development, Sales and Marketing India, harm, hepatitis, patent, patient access, sovaldi

Gilead has been granted a patent for its hepatitis C drug, Sovaldi (sofosbuvir), in India which has sparked dismay among …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026